Molecular Endocrinology and Metabolism
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish original contributions and reviews on all aspects of endocrinology and metabolism. We encourage the submission of manuscripts that report significant advances in those fields. Topics include, but are not limited to, the following:
- Endocrine systems and endocrine-related diseases;
- Molecular, cellular, genetic, epigenetic, developmental approaches, and animal models;
- Novel insights into physiology, pathophysiology, and therapeutics;
- Neuroendocrinology and neuroendocrine control of endocrine axes;
- Classical glands (thyroid, adrenal, pituitary, parathyroid, testis, ovary, pituitary, etc.) and other endocrine systems: gut, bone, liver, etc.;
- Lipids and bone metabolism;
- Hormones, paracrine factors, receptors and binding components, nuclear receptors membrane receptors, signal transduction pathway;
- Steroid biosynthetic enzymes, metabolism of hormones, neurotransmitters, etc.;
- Cellular interactions and factors involved;
- Energy expenditure;
- Diabetes;
- Infertility and reproductive diseases;
- Obesity;
- Osteoporosis;
- Aging;
- Endocrine-related tumor and cancer;
- Endocrine disruption;
- Crossdisciplinary and integrative studies;
- Comparative aspects of endocrinology.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights 2.0 (Deadline: 30 May 2022)
- Adipokines in Health and Diseases 2.0 (Deadline: 30 May 2022)
- The Role of Tissue-Nonspecific Alkaline Phosphatase in Inflammation and Metabolic Syndrome 2.0 (Deadline: 30 May 2022)
- MicroRNA, Insulin Resistance, and Metabolic Disorders (Deadline: 31 May 2022)
- Extracellular Vesicles in Reproduction 2.0 (Deadline: 31 May 2022)
- Biomarkers for Early Detection of Cancer: Molecular Aspects (Deadline: 31 May 2022)
- Role of Aldosterone Excess in Determining Cardiovascular Risk (Deadline: 31 May 2022)
- Molecular Mechanism Underlying the Endocrine Abnormalities Associated with Severe Illness (Deadline: 31 May 2022)
- Epilepsy and Metabolism (Deadline: 31 May 2022)
- Type 2 Diabetes: Advances on Pathophysiology and Therapies (Deadline: 31 May 2022)
- Prevention and Drug Treatment of Breast Cancer (Deadline: 31 May 2022)
- Endothelial Cell Senescence in Ageing and Disease (Deadline: 31 May 2022)
- The Tumor Metabolism at the Intersection between Molecular Biology and Physics (Deadline: 31 May 2022)
- New Advance in Diabetes Genetics (Deadline: 31 May 2022)
- Breast Cancer Chemotherapy (Deadline: 31 May 2022)
- Local Control of Thyroid Hormone Action (Deadline: 31 May 2022)
- Metabolic Therapies for Heart Failure (Deadline: 31 May 2022)
- Sphingolipids: Metabolic Functions and Disorders 2.0 (Deadline: 31 May 2022)
- Epigenetics, Exosomes, and MicroRNAs in Metabolic Disorders (Deadline: 31 May 2022)
- Molecular Mechanism of Hypothyroidism (Deadline: 31 May 2022)
- Molecular Frontiers in Inflammatory Bowel Diseases (Deadline: 31 May 2022)
- Lipids and Lipoproteins in Metabolic Diseases (Deadline: 31 May 2022)
- Obesity and Arterial Hypertensionis (Deadline: 31 May 2022)
- Metabolism Signaling and Gene Regulation in Human Health (Deadline: 20 June 2022)
- 2nd Edition: The Role of Interleukin in Health and Diseases (Deadline: 29 June 2022)
- Steroidomics in Physiology and Pathophysiology (Deadline: 30 June 2022)
- Molecular Pathways for Vascular Risk in Diabetes (Deadline: 30 June 2022)
- Molecular Research in Circadian Rhythm and Cellular Synchrony (Deadline: 30 June 2022)
- Antimicrobial Strategies in Nanomedicine (Deadline: 30 June 2022)
- Hormone Signaling in Human Health and Diseases (Deadline: 30 June 2022)
- Lipids and Brain Aging (Deadline: 30 June 2022)
- Regulation of Substrate Metabolism for Energy (Deadline: 30 June 2022)
- Molecular Mechanisms of Gut Microbiota Impacting Cardiometabolic Function (Deadline: 30 June 2022)
- Transcriptional Control of Metabolism in Cancers (Deadline: 30 June 2022)
- Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies 2.0 (Deadline: 30 June 2022)
- Molecular Research of Urology 2022 (Deadline: 30 June 2022)
- Molecular Mechanisms of Muscle Fatigue (Deadline: 30 June 2022)
- Molecular Advances in Prostate Cancer (Deadline: 30 June 2022)
- Molecular and Cellular Mechanisms of Gynecologic Malignancies, Benign Diseases, and Their Medications (Deadline: 30 June 2022)
- Adaptation to Hypoxia: Beyond the Chimera (Deadline: 30 June 2022)
- Mechanisms of Endocrine and Molecular Bone Regulation (Deadline: 30 June 2022)
- Lipid and Fatty Acid Metabolism in Cardiovascular Diseases (Deadline: 30 June 2022)
- Role of Interleukin Genes in Etiopathogenesis of Multifactorial Traits and Diseases (Deadline: 30 June 2022)
- The Role of Estrogen Receptors in Health and Disease 2.0 (Deadline: 30 June 2022)
- Molecular Mechanisms of Human Oogenesis and Early Embryogenesis (Deadline: 30 June 2022)
- New Insights on Roles of Glycoconjugates in Health and Diseases (Deadline: 30 June 2022)
- Modelling Biological Barriers to Study Molecular Trafficking In Vitro: Advances and Applications (Deadline: 30 June 2022)
- Disease Associated Macrophages: Old and New Standpoints (Deadline: 30 June 2022)
- Hormone Secretion and Molecular Alterations in Pancreatic Cell Systems and Metabolic-Related Tissues (Deadline: 30 June 2022)
- Molecular Advances in Osteoporosis Research (Deadline: 15 July 2022)
- Endothelial Progenitor Cells in Health and Disease 2.0 (Deadline: 15 July 2022)
- Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives 4.0 (Deadline: 15 July 2022)
- The Biology and Pharmacology of Glucagon 2.0 (Deadline: 15 July 2022)
- Amino Acid Metabolism and Disease (Deadline: 20 July 2022)
- Female Reproduction: The Link between Basic Ovarian Events and the Microenvironment of the Oocyte (Deadline: 30 July 2022)
- Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity till New Therapeutic Approaches 2.0 (Deadline: 31 July 2022)
- Molecular Biology of Gestational Diabetes: The Culprit of the Diabetes Pandemic (Deadline: 31 July 2022)
- Colorectal Cancer and Adjacent Normal Mucosa Differ in Apoptotic and Inflammatory Protein Expression (Deadline: 31 July 2022)
- Central and Local Modulators of Reproduction and Fertility: An Update 2.0 (Deadline: 31 July 2022)
- Molecular Pathways in Diabetic Cardiomyopathy (Deadline: 31 July 2022)
- Mechanisms of Insulin Resistance and Adipose Tissue Dysfunction (Deadline: 31 July 2022)
- Molecular Biomarkers in Cancer and Metabolic Disease 2.0 (Deadline: 31 July 2022)
- Molecular and Hormonal Advances in Amenorrhea (Deadline: 31 July 2022)
- Proteolysis of Extracellular Matrix in Human Disease 2.0 (Deadline: 31 July 2022)
- Antioxidants and Obesity 2.0 (Deadline: 31 July 2022)
- Mechanisms Linking Metabolism and Reproductive Diseases (Deadline: 31 July 2022)
- Novel Insights into Physical Exercise and Muscle Metabolism (Deadline: 31 July 2022)
- Micronutrients in Metabolic Health (Deadline: 31 July 2022)
- Disturbances of Circadian Hormonal and Metabolic Rhythms in a Changing Environment (Deadline: 31 July 2022)
- Molecular Frontiers in Transplantation-Induced Ischemia Reperfusion Injury (Deadline: 31 July 2022)
- Lipid Metabolism in Pathology and Health (Deadline: 31 July 2022)
- Micronutrients, Overweight, and Obesity (Deadline: 31 July 2022)
- Modulation of Signaling Pathways Controlling the Energy Balance in Cancer (Deadline: 31 July 2022)
- The Role of the IGF Axis in Disease 2.0 (Deadline: 31 July 2022)
- Melatonin in Disease and Health 2.0 (Deadline: 31 July 2022)
- Mitochondrial Function and Communication 2.0 (Deadline: 30 August 2022)
- Frontiers in Thrombosis (Deadline: 30 August 2022)
- Molecular and Cellular Advances in Endometriosis Research 2.0 (Deadline: 30 August 2022)
- The Role of PARPs in Cancer and Aging (Deadline: 31 August 2022)
- New Advances in Endocrine-Related Cancer 2022 (Deadline: 31 August 2022)
- Molecular Basis of Fertility Preservation and Restoration 3.0 (Deadline: 31 August 2022)
- Solving the Puzzle: Molecular Research in Inflammatory Bowel Diseases (Deadline: 31 August 2022)
- The Products of Bone Resorption and Their Role in Metabolism (Deadline: 31 August 2022)
- Recent Aspects in the Pathogenesis and Molecular Mechanism of Vascular Endothelial Inflammation in Metabolic Diseases (Deadline: 31 August 2022)
- Molecular Pathophysiology of Uterine and Ovarian Diseases and Dysfunction 3.0 (Deadline: 31 August 2022)
- Targeting Mitochondria in Metabolic Diseases 2.0 (Deadline: 31 August 2022)
- Advances in Skeletal Muscle Function and Metabolism (Deadline: 31 August 2022)
- Mammalian Gametes: Molecular Traits Shaping Their Form and Fate 2.0 (Deadline: 31 August 2022)
- Mesenchymal Stem Cell 2.0: Greater Opportunities for Applications in Human Diseases (Deadline: 31 August 2022)
- Molecular and Cellular Exercise Physiology in Metabolism (Deadline: 31 August 2022)
- Bladder Cancer: Molecular Advances in Pathology, Diagnostics, and Therapeutics (Deadline: 31 August 2022)
- The Role of TRAIL in Human Health and Metabolic Disorders (Deadline: 15 September 2022)
- New Advance in Neuroinflammation (Deadline: 20 September 2022)
- Metabolic Regulation in the Development of Cardiovascular Disease and Heart Failure (Deadline: 30 September 2022)
- Post-transcriptional Gene Expression Regulation in Eukaryotic Energy Metabolism (Deadline: 30 September 2022)
- Disorders of Bone Metabolism (Deadline: 30 September 2022)
- Novel Biomarkers in Obesity and Metabolic Syndromes: Therapeutic Indicators and Outcome Predictors (Deadline: 30 September 2022)
- Diet and Lifestyle: Impact on the Molecular and Cellular Mechanism of NCDs (Deadline: 30 September 2022)
- Adenylate Kinase in Human Health and Disease (Deadline: 30 September 2022)
- New Advances in Osteoarthritis (Deadline: 30 September 2022)
- Molecular Advances on Insulin Resistance and Metabolic Dysfunction (Deadline: 30 September 2022)
- Hormones and Drugs Effect on Weight Control and Disorders (Deadline: 30 September 2022)
- Molecular Research in Embryo Implantation (Deadline: 30 September 2022)
- Inflammatory and Metabolic Dysregulations in Chronic Liver and Pancreas Disorders (Deadline: 30 September 2022)
- Angiogenesis and Lymphangiogenesis: From Molecular Regulation to Therapeutic Application (Deadline: 30 September 2022)
- Role of Dysfunctional Adipose Tissue in the Pathogenesis of Multiple Organ Injuries (Deadline: 30 September 2022)
- Association of Gut Microbiome and Food Allergies by –Omics Strategies (Deadline: 30 September 2022)
- Focus on Gastrointestinal Diseases 2.0: Inflammation (Deadline: 30 September 2022)
- Hypothalamic Regulation of Obesity and Diabetes (Deadline: 30 September 2022)
- Molecular Research in Primary Osteoporosis (Deadline: 30 September 2022)
- Epigenetic Mechanisms and Inflammatory Response in Endocrine Disorders (Deadline: 30 September 2022)
- The Role of Vitamin D in Human Health and Diseases 2.0 (Deadline: 30 September 2022)
- Impact of Endogenic and Exogenic Oxidative Stress Triggers on Pregnant Woman, Fetus, and Child (Deadline: 30 September 2022)
- Lipid Metabolism and Signaling in Tumors and Cerebrovascular Diseases 2.0 (Deadline: 30 September 2022)
- Translational Research on Leukemia (Deadline: 30 September 2022)
- Novel Drugs for Infertility Treatment in 2022 (Deadline: 30 September 2022)
- Roles and Function of Extracellular Vesicles in Diseases (Deadline: 30 September 2022)
- Cellular and Molecular Mechanisms of Cardiovascular and Metabolic Diseases (Deadline: 30 September 2022)
- Oxidative Stress and Metabolic Diseases (Deadline: 30 September 2022)
- New Advance in Insulin and Insulin Receptor (Deadline: 30 September 2022)
- Preventive and Therapeutic Strategies in Vascular Dysfunction (Deadline: 30 September 2022)
- Pleiotropic Benefits of Melatonin: From Basic Mechanisms to Disease (Deadline: 30 September 2022)
- Chronic Kidney Disease: Underlying Molecular Mechanisms (Deadline: 5 October 2022)
- Redox Physiology in Biomedicine and Ecophysology: Influence of Various Substances in Redox Regulation of Cell Metabolism (Deadline: 11 October 2022)
- Chronic Inflammation and Related Diseases: From Mechanisms to Therapies (Deadline: 30 October 2022)
- Venous Thromboembolism, Coagulation, Metabolism and Cancer (Deadline: 30 October 2022)
- Mitochondrial and Calcium Signaling in Human Health and Disease (Deadline: 31 October 2022)
- Molecular Gateways to Polycystic Ovary Syndrome (Deadline: 31 October 2022)
- Novel Therapeutic Targets for Tumor Microenvironment in Cancer (Deadline: 31 October 2022)
- Steroid Metabolism in Human Health and Disease 2.0 (Deadline: 31 October 2022)
- Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches (Deadline: 31 October 2022)
- Secondary Osteoporosis in Adults 3.0 (Deadline: 31 October 2022)
- Molecular Research on Bladder Cancer (Deadline: 31 October 2022)
- From Molecular Mechanisms to Therapy: Novel Insight on Musculoskeletal System (Deadline: 31 October 2022)
- Frontiers in Obesity (Deadline: 31 October 2022)
- Recent Research on Diabetes Mellitus and Its Complications 2.0 (Deadline: 15 November 2022)
- The Natriuretic Peptide Family: A Single Entity, Pleiotropic Effects (Deadline: 15 November 2022)
- Peripheral Artery Disease: Inflammatory, Metabolic and Coagulative Pathogenetic Implications (Deadline: 15 November 2022)
- Novel Aspects in Kidney Disease in Diabetes 2.0 (Deadline: 30 November 2022)
- Toxic Liver Injury: Molecular, Mechanistic, and Medical Challenges 2.0 (Deadline: 30 November 2022)
- Molecular Advances in Age-Related Diseases (Deadline: 30 November 2022)
- Cellular Stress Response in Metabolic Syndrome (Deadline: 30 November 2022)
- State-of-the-Art Molecular Endocrinology and Metabolism in USA (Deadline: 30 November 2022)
- New Techniques and Insights in Endocrine Homeostasis and Metabolic Diseases (Deadline: 30 November 2022)
- New Molecular Testing for Cytologically Indeterminate Thyroid Nodules (Deadline: 30 November 2022)
- New Technique and Insights in Endocrine Homeostasis and Metabolic Diseases (Deadline: 30 November 2022)
- Thyroid Autoimmune Disorders and Cancer (Deadline: 30 November 2022)
- Skeletal Muscle and Physical Exercise (Deadline: 30 November 2022)
- Bone Ontogeny, Embryology, and Homeostasis 2.0 (Deadline: 30 November 2022)
- Steroids and Lipophilic Hormones, and Their Actions 3.0 (Deadline: 30 November 2022)
- Mitochondria in Human Health and Disease (Deadline: 30 November 2022)
- Molecular Metabolisms in Cartilage Health and Diseases 2.0 (Deadline: 30 November 2022)
- Amino Acid Metabolism: Design, Nutrition, and Disorders (Deadline: 30 November 2022)
- Molecular Research in Adrenal Diseases (Deadline: 30 November 2022)
- Lipid Metabolism in Human Diseases (Deadline: 30 November 2022)
- Serotonin Network and Energy Metabolism (Deadline: 30 November 2022)
- COVID-19, Diabetes, Obesity and Cardiometabolic Alterations: Recent Findings and Future Perspectives (Deadline: 31 December 2022)
- mTOR, Metabolism, and Diseases 2.0 (Deadline: 31 December 2022)
- Molecular Biomarkers in Cancer and Chronic Inflammation: New Therapeutic Approaches (Deadline: 31 December 2022)
- Osteoarthritis 2.0: From Molecular Pathways to Therapeutic Advances (Deadline: 31 December 2022)
- Metabolism Disrupting Chemicals: Screening, Testing and Molecular Pathway Identification (Deadline: 31 December 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
- 21st Anniversary of IJMS: Advances in Molecular Endocrinology and Metabolism
- Bone and Cartilage Diseases
- State-of-the-Art Molecular Endocrinology and Metabolism in France
- State-of-the-Art Molecular Endocrinology and Metabolism in Italy
- State-of-the-Art Molecular Endocrinology and Metabolism in Japan
- State-of-the-Art Molecular Endocrinology and Metabolism in Korea
- State-of-the-Art Molecular Endocrinology and Metabolism in Spain
- State-of-the-Art Molecular Endocrinology and Metabolism in UK
